These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains. Brauers J; Frank U; Kresken M; Rodloff AC; Seifert H Clin Microbiol Infect; 2005 Jan; 11(1):24-30. PubMed ID: 15649300 [TBL] [Abstract][Full Text] [Related]
5. [Antimicrobial resistance of different Acinetobacter baumannii biotypes isolated in the northern region of Chile]. Silva J; Avello C; Matamoro F; Villagra L; Rojas V; Sandoval L Rev Med Chil; 1999 Aug; 127(8):926-34. PubMed ID: 10752253 [TBL] [Abstract][Full Text] [Related]
6. [In vitro activity of azithromycin against clinical isolates of Acinetobacter baumannii]. Fernández Cuenca F; Pascual A; Martínez Martínez L; Perea EJ Rev Esp Quimioter; 2003 Jun; 16(2):204-8. PubMed ID: 12973458 [TBL] [Abstract][Full Text] [Related]
7. [Activity of beta-lactamase inhibitors against Acinetobacter baumannii]. Fernández Cuenca F Rev Esp Quimioter; 1998 Dec; 11(4):384-5. PubMed ID: 10336325 [No Abstract] [Full Text] [Related]
8. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii]. Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore. Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL J Antibiot (Tokyo); 2009 Dec; 62(12):675-9. PubMed ID: 19876075 [TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan. Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353 [TBL] [Abstract][Full Text] [Related]
12. [Study on a bacterial strain Bt8 for biocontrol against citrus bacterial canker]. Tan XY; Huang SL; Ren JG; Yan WH; Cen ZL Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):292-6. PubMed ID: 16736594 [TBL] [Abstract][Full Text] [Related]
13. [Detection of integron, homology and genotype of carbapenemases in multi-drug resistant Acinetobacter Baumannii isolated from burn wound]. Jiang LY; Xue XD; Wei LH; Si XQ; Liu G; Zhou H; Yu YS Zhonghua Shao Shang Za Zhi; 2008 Dec; 24(6):432-6. PubMed ID: 19149944 [TBL] [Abstract][Full Text] [Related]
14. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672 [TBL] [Abstract][Full Text] [Related]
15. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates]. López-Hernández S; Alarcón T; López-Brea M Rev Esp Quimioter; 2000 Dec; 13(4):394-400. PubMed ID: 11498706 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand. Tiengrim S; Tribuddharat C; Thamlikitkul V J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251 [TBL] [Abstract][Full Text] [Related]
17. Relationship between antimicrobial resistance and aminoglycoside-modifying enzyme gene expressions in Acinetobacter baumannii. Shi WF; Jiang JP; Mi ZH Chin Med J (Engl); 2005 Jan; 118(2):141-5. PubMed ID: 15667800 [TBL] [Abstract][Full Text] [Related]
18. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem. Pachón-Ibáñez ME; Jiménez-Mejías ME; Pichardo C; Llanos AC; Pachón J Antimicrob Agents Chemother; 2004 Nov; 48(11):4479-81. PubMed ID: 15504889 [TBL] [Abstract][Full Text] [Related]
19. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Rice LB Clin Infect Dis; 2006 Sep; 43 Suppl 2():S100-5. PubMed ID: 16894511 [TBL] [Abstract][Full Text] [Related]
20. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii. Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]